Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
Authors:
Open Access
- 15 July 2016
- journal article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 10 (4) , 493-494
Abstract
Jung Hwa Min, and You Sun Kim. Gut and Liver 2016;10:493-4. https://doi.org/10.5009/gnl16216Keywords
This publication has 12 references indexed in Scilit:
- Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill PatientsGut and Liver, 2016
- A Case of Toxic Megacolon Caused by Clostridium difficile Infection and Treated with Fecal Microbiota TransplantationGut and Liver, 2015
- 'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?Intestinal Research, 2015
- Clostridium difficileInfection: A Worldwide DiseaseGut and Liver, 2014
- Long-Term Clinical Outcome ofClostridium difficileInfection in Hospitalized Patients: A Single Center StudyIntestinal Research, 2014
- Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill PatientsCritical Care Medicine, 2013
- Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-AnalysisAmerican Journal of Gastroenterology, 2012
- Incidence and clinical features ofClostridium difficileinfection in Korea: a nationwide studyEpidemiology and Infection, 2012
- Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in QuebecClinical Infectious Diseases, 2005
- Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severityCanadian Medical Association Journal, 2004